Steven Schoenfeld
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Steven Schoenfeld
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 4 | |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA.
3
| Subsidiary | Hospital/Nursing Management | 3 |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA.
3
| Subsidiary | Biotechnology | 3 |
CovX Research LLC
CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million.
2
| Subsidiary | Biotechnology | 2 |
Ciba-Geigy Pharmaceuticals
1
| Subsidiary | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Steven Schoenfeld via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Monogram Biosciences, Inc.
Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Sales & Marketing | |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology. | Investment Banks/Brokers | Analyst-Equity | |
EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIOCEPT, INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Medical Specialties | President | |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
OrbiMed Israel Partners LP
OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Investment Managers | Director/Board Member | |
TRANSLATE BIO, INC. | Biotechnology | Director/Board Member | |
River Vision Development Corp.
River Vision Development Corp. BiotechnologyHealth Technology River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Tacora Corp
Tacora Corp Miscellaneous Commercial ServicesCommercial Services Part of Abeona Therapeutics, Inc., Tacora Corp is an investment manager that provides creative financing solutions to capital-intensive venture-backed companies in sectors such as fintech, insuretech, and proptech. The company is based in Seattle, WA. The company's investment objective is to generate returns through income from credit and credit-like instruments, and long-term equity upside through warrants. Tacora was acquired by Abeona Therapeutics, Inc. on April 26, 1996 for $14 million. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Oppenheimer & Co., Inc. (Broker)
Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Oppenheimer & Co., Inc. (Broker) (Oppenheimer-Broker) is the global full-service brokerage division of Oppenheimer & Co., Inc., an investment boutique headquartered in New York City with additional offices nationwide. Founded in 1975, the firm is owned directly by Viner Finance Inc., an indirect subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY). Oppenheimer-Broker offers a full array of brokerage services to retail, institutional, and corporate clients. | Investment Banks/Brokers | Analyst-Equity | |
University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree | |
Fairleigh Dickinson University | College/University | Undergraduate Degree | |
Tulane University (Louisiana) | College/University | Undergraduate Degree | |
University of Massachusetts | College/University | Undergraduate Degree | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Private Equity Investor | |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
EFFECTOR THERAPEUTICS, INC. | Biotechnology | Chairman | |
University of Michigan | College/University | Doctorate Degree | |
Caring Brands, Inc.
Caring Brands, Inc. Medical/Nursing ServicesHealth Services Part of Safety Shot, Inc., Caring Brands, Inc. is a company that provides home healthcare services. The company is based in Jupiter, FL. | Medical/Nursing Services | Director/Board Member | |
PharmaSpec Corp. | President | ||
The Rockefeller University | College/University | Doctorate Degree | |
SAFETY SHOT, INC. | Household/Personal Care | Chairman | |
Tapimmune, Inc. | Chief Executive Officer | ||
CADRENAL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
The University of Cincinnati College of Medicine | College/University | Doctorate Degree | |
A.B. Freeman School of Business | College/University | Masters Business Admin | |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Sales & Marketing | |
QUALIGEN THERAPEUTICS, INC. | Pharmaceuticals: Other | President | |
The University of Colorado School of Medicine | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 49 |
Japan | 2 |
Sectoraal
Health Technology | 27 |
Consumer Services | 10 |
Finance | 7 |
Commercial Services | 4 |
Retail Trade | 2 |
Operationeel
Director/Board Member | 53 |
Corporate Officer/Principal | 49 |
Director of Finance/CFO | 14 |
Undergraduate Degree | 12 |
Independent Dir/Board Member | 11 |
Sterkste connecties
Insiders | |
---|---|
Julia Brown | 27 |
Brian Gallagher | 20 |
Linda Rubinstein | 16 |
Kent Alan Gossett | 16 |
Simon Allen | 13 |
Glynn Wilson | 13 |
Blaine McKee | 13 |
Michael Dunn | 12 |
Catherine Lee Kelleher | 8 |
Gregory Zante | 7 |
Michael A. Dinerman | 7 |
Amy Broidrick | 6 |
Douglas Hunt | 5 |
- Beurs
- Insiders
- Steven Schoenfeld
- Bedrijfsconnecties